Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Entera Bio Stock News

ENTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Entera Bio (ENTX) Forecast

News

Earnings Entera Bio (ENTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Entera Bio Stock News | NASDAQ:ENTX | Benzinga

Get the latest news on Entera Bio stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Entera Bio performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, April 15, 2025

Entera Bio Announces EB613 Impact On Both Tra...
Benzinga Newsdesk - 1 day ago

Friday, March 28, 2025

Entera Bio FY 2024 GAAP EPS $(0.25), Sales $1...
Benzinga Newsdesk - Mar 28, 2025, 4:09PM

Tuesday, March 18, 2025

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Mar 18, 2025, 11:47AM

Monday, March 17, 2025

Entera Bio shares are trading higher after en...
Benzinga Newsdesk - Mar 17, 2025, 8:55AM
OPKO Health And Entera Bio Enter Collaboratio...
Benzinga Newsdesk - Mar 17, 2025, 8:02AM

Wednesday, February 19, 2025

Entera Bio's EB613 Abstracts For Osteoporosis...
Benzinga Newsdesk - Feb 19, 2025, 8:04AM

Monday, November 11, 2024

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Nov 11, 2024, 6:57AM

Friday, November 08, 2024

Entera Bio Q3 2024 GAAP EPS $(0.08) Misses $(...
Benzinga Newsdesk - Nov 8, 2024, 4:10PM

Monday, October 07, 2024

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Oct 7, 2024, 6:31AM

Friday, September 27, 2024

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Sep 27, 2024, 6:34AM

Wednesday, September 25, 2024

Entera Bio shares are trading higher after th...
Benzinga Newsdesk - Sep 25, 2024, 9:31AM
Entera Bio And OPKO Health Announce PK/PD Res...
Benzinga Newsdesk - Sep 25, 2024, 8:34AM

Monday, August 12, 2024

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Aug 12, 2024, 6:55AM

Friday, August 09, 2024

Entera Bio Q2 EPS $(0.06), Inline, Sales $57....
Benzinga Newsdesk - Aug 9, 2024, 4:09PM

Thursday, August 01, 2024

Entera To Present EB613, Once Daily PTH(1-34)...
Benzinga Newsdesk - Aug 1, 2024, 8:40AM

Wednesday, June 05, 2024

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Jun 5, 2024, 7:02AM

Monday, June 03, 2024

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks - Jun 3, 2024, 3:32PM
Entera Bio Presents Phase 1 Clinical Data Of ...
Benzinga Newsdesk - Jun 3, 2024, 8:14AM

Tuesday, May 14, 2024

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - May 14, 2024, 6:31AM

Monday, May 13, 2024

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - May 13, 2024, 7:58AM

Friday, May 10, 2024

Entera Bio Q1 EPS $(0.05) Beats $(0.06) Estim...
Benzinga Newsdesk - May 10, 2024, 4:18PM

Monday, April 08, 2024

Entera Bio Announces Publication Of Oral PTH(...
Benzinga Newsdesk - Apr 8, 2024, 8:33AM

Tuesday, April 02, 2024

HC Wainwright & Co. Maintains Buy on Entera B...
Benzinga Newsdesk - Apr 2, 2024, 8:54AM

Tuesday, March 26, 2024

Entera Bio Announces Key Regulatory Milestone For Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling On Qualifying BMD As A Surrogate Endpoint For Osteoporosis Drugs is Expected Within 10 Months
Happy Mohamed - Mar 26, 2024, 8:33AM

Wednesday, March 20, 2024

Entera Bio Announces Pharmacokinetic Data For...
Benzinga Newsdesk - Mar 20, 2024, 8:03AM

Friday, March 08, 2024

Entera Bio FY23 EPS $(0.31) Vs $(0.41) YoY; A...
Benzinga Newsdesk - Mar 8, 2024, 4:17PM

Monday, March 04, 2024

Entera Bio Regains Compliance With Nasdaq Min...
Benzinga Newsdesk - Mar 4, 2024, 8:47AM

Friday, January 12, 2024

Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying
Avi Kapoor - Jan 12, 2024, 7:48AM

Wednesday, January 03, 2024

Entera Bio Announced That It Received An Exte...
Benzinga Newsdesk - Jan 3, 2024, 8:49AM

Monday, December 11, 2023

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Dec 11, 2023, 6:42AM

Wednesday, November 29, 2023

Interim Results From Ongoing Clinical Study C...
Benzinga Newsdesk - Nov 29, 2023, 8:33AM

Monday, October 16, 2023

Entera Bio Reports Rapid Pharmacodynamic Resp...
Benzinga Newsdesk - Oct 16, 2023, 8:20AM

Wednesday, September 13, 2023

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Sep 13, 2023, 6:33AM

Tuesday, September 12, 2023

Entera Bio Announces Collaboration with OPKO ...
Benzinga Newsdesk - Sep 12, 2023, 8:32AM

Monday, September 11, 2023

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Sep 11, 2023, 6:32AM

Wednesday, August 23, 2023

Bioventus And 3 Other Stocks Under $5 Insiders Are Buying
Lisa Levin - Aug 23, 2023, 9:23AM

Wednesday, August 16, 2023

Entera Bio To Present Two Abstracts On Its On...
Benzinga Newsdesk - Aug 16, 2023, 8:35AM

Monday, May 08, 2023

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - May 8, 2023, 6:28AM

Friday, May 05, 2023

Entera Bio: Q1 Earnings Insights
Benzinga Insights - May 5, 2023, 4:10PM
Entera Bio Q1 EPS $(0.08) Beats $(0.12) Estim...
Benzinga Newsdesk - May 5, 2023, 4:07PM

Tuesday, April 04, 2023

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Apr 4, 2023, 6:42AM

Monday, April 03, 2023

Reported Earlier, Entera Bio Provides Guidance From FDA Type D Meeting Related To EB613 Pivotal Program
Happy Mohamed - Apr 3, 2023, 8:18AM

Tuesday, March 28, 2023

HC Wainwright & Co. Reiterates Buy on Entera ...
Benzinga Newsdesk - Mar 28, 2023, 6:29AM

Thursday, March 23, 2023

Entera Bio Regains Compliance With Nasdaq Listing Requirements
Happy Mohamed - Mar 23, 2023, 9:48AM

Tuesday, March 07, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Mar 7, 2023, 1:02PM
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 7, 2023, 7:51AM

Monday, March 06, 2023

Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin - Mar 6, 2023, 1:25PM
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Mar 6, 2023, 7:54AM

Wednesday, February 15, 2023

Entera Bio Announces FDA's Acceptance Of A Type D Meeting Review To Affirm Design Of The Pivotal, Phase 3 Protocol For EB613 PTH Mini Tablets, As The First Oral Osteoanabolic Treatment Of Post-Menopausal Osteoporosis
Happy Mohamed - Feb 15, 2023, 10:01AM

Wednesday, January 04, 2023

Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jan 4, 2023, 7:59AM

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved